Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 99/100Confidence medium
biorxiv2026-08-14OXPHOSmetabolismneurobiologyimmunology

Neuroinflammation and metabolic dysfunction in POLG-related mitochondrial epilepsy

Scientific focus: OXPHOS, metabolism, neurobiology, immunology. Core claim (from abstract): The neuropathological mechanisms underlying POLG-related mitochondrial epilepsy remain poorly understood, however, neuroinflammation and glial dysfunction are hypothesised to play a significant role. Dysfunction linkage: mitochondrial dysfunction; OXPHOS / ETC; disease context; inflammation. High priority for readers tracking mitochondrial pathophysiology and translational mito biology.

Mito.news · at a glance

Signal profile (abstract-level)

OXPHOS · metabolism · neurobiology · immunology

Score 99/100BIORXIVmedium confidenceOXPHOS
99
Importance
77
Mito signal
100
Dysfunction
83
Evidence
50
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Verdict. The neuropathological mechanisms underlying POLG-related mitochondrial epilepsy remain poorly understood, however, neuroinflammation and glial dysfunction are hypothesised to play a significant role. It intersects mitochondrial stress/dysfunction themes (mitochondrial dysfunction; OXPHOS / ETC; disease context).

What the authors report

Super-refractory status epilepticus is a common neurological manifestation of mitochondrial disease caused by bi-allelic pathogenic variants in POLG. Epilepsy in POLG-related disease typically presents with an explosive onset of status epilepticus, often from an occipital focus, and is associated with extensive neurodegeneration.

Key results stated in the abstract include the following. The neuropathological mechanisms underlying POLG-related mitochondrial epilepsy remain poorly understood, however, neuroinflammation and glial dysfunction are hypothesised to play a significant role. In this study, we performed a neuropathological and proteomic investigation of post-mortem brain tissues from 12 patients with POLG-related mitochondrial epilepsy (age range: 3 - 28 years) and matched control cases. To validate these observations, we confirmed an increased density of cells immunoreactive for acute phase proteins (C-reactive protein, osteopontin and serpin A3), immune co-receptors (CD14 and HLA-DR), the inflammatory glycoprotein YKL40, the cytokine TNF-alpha, and mitochondrial translocator protein (TSPO).

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to OXPHOS, metabolism, neurobiology, immunology. It is relevant to mitochondrial dysfunction discourse because the abstract invokes mitochondrial dysfunction, OXPHOS / ETC, disease context, inflammation. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. OXPHOS/ETC involvement, if confirmed, would place the work in the core of bioenergetic pathophysiology rather than peripheral organelle biology. Server: biorxiv. Posted 2026-08-14. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

In this study, we performed a neuropathological and proteomic investigation of post-mortem brain tissues from 12 patients with POLG-related mitochondrial epilepsy (age range: 3 - 28 years) and matched control cases. We also demonstrate a decreased expression of mitochondrial oxidative phosphorylation (OXPHOS) subunits within POLG patient microglia, indicative of mitochondrial dysfunction.

Principal findings

  1. The neuropathological mechanisms underlying POLG-related mitochondrial epilepsy remain poorly understood, however, neuroinflammation and glial dysfunction are hypothesised to play a significant role.
  2. In this study, we performed a neuropathological and proteomic investigation of post-mortem brain tissues from 12 patients with POLG-related mitochondrial epilepsy (age range: 3 - 28 years) and matched control cases.
  3. To validate these observations, we confirmed an increased density of cells immunoreactive for acute phase proteins (C-reactive protein, osteopontin and serpin A3), immune co-receptors (CD14 and HLA-DR), the inflammatory glycoprotein YKL40, the cytokine TNF-alpha, and mitochondrial translocator protein (TSPO).
  4. We also demonstrate a decreased expression of mitochondrial oxidative phosphorylation (OXPHOS) subunits within POLG patient microglia, indicative of mitochondrial dysfunction.
  5. Finally, we show enrichment of mitochondrial OXPHOS and interneuron proteins in the control primary visual cortex compared with the frontal cortex, which may underlie the selective regional vulnerability observed in POLG-related mitochondrial disease.

Limitations of this brief

  • This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
  • Preprint status: findings may change with revision or journal review.
  • Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
  • Primary source: biorxiv DOI 10.64898/2026.08.12.744403 (posted 2026-08-14).

Open scientific questions

  • Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
  • Are OXPHOS defects primary drivers or secondary consequences of broader cellular stress?
  • Is the mitochondrial phenotype cell-autonomous in neurons/glia, or secondary to systemic/inflammatory signals?
  • How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on OXPHOS, metabolism, neurobiology, this preprint is worth full-text review soon. Abstract-level takeaway: The neuropathological mechanisms underlying POLG-related mitochondrial epilepsy remain poorly understood, however, neuroinflammation and glial dysfunction are hypothesised to play a significant role. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

FieldValue
TitleNeuroinflammation and metabolic dysfunction in POLG-related mitochondrial epilepsy
DOI10.64898/2026.08.12.744403
Serverbiorxiv
Posted2026-08-14
TopicsOXPHOS, metabolism, neurobiology, immunology
Mitos score99/100
Confidencemedium
HTMLhttps://www.biorxiv.org/content/10.64898/2026.08.12.744403
PDFhttps://www.biorxiv.org/content/10.64898/2026.08.12.744403.full.pdf

Abstract-based editorial synthesis by Mitos. Not peer review.

Test bot purchase (MetaMask)

Free HTML is above. To pay for the same content as JSON (bot path), open the purchase tester:

Buy JSON with MetaMask ($0.005)

Bot URL: /api/v1/papers/10-64898-2026-08-12-744403

Source preprint

Neuroinflammation and metabolic dysfunction in POLG-related mitochondrial epilepsy

10.64898/2026.08.12.744403

Smith LA, Wilson M, Mohamed Elsaid E, Palmowski P, Jiang Z, Aryeetey L, Holly C, Dickin J, Abbey M, Smith AL, Taylor RW, Hikmat O, Tzoulis C, Hudson G, Erskine D, McFarland R.

Related briefs